Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues for statisticians in pharmaco-economic evaluations

A P Grieve1

  • 1Biometrics Department, Pfizer Central Research, Sandwich, Kent, U.K.

Statistics in Medicine
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children.

Allergy·2012
Same author

Visible iris sign as a predictor of problems during and following anterior approach ptosis surgery.

Eye (London, England)·2010
Same author

[The German version of the satisfaction with stroke care questionnaire (SASC) for stroke patients].

Fortschritte der Neurologie-Psychiatrie·2010
Same author

Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register.

Journal of neurology, neurosurgery, and psychiatry·2009
Same author

Black and minority ethnic men who have sex with men: a London genitourinary medicine clinic experience.

International journal of STD & AIDS·2008
Same author

Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".

Journal of biopharmaceutical statistics·2007
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study explores statistical methods for pharmaceutical economic evaluations. It discusses the suitability of randomized clinical trials and advanced techniques for analyzing cost-effectiveness data.

Area of Science:

  • Health Economics
  • Biostatistics
  • Pharmaceutical Sciences

Background:

  • Economic evaluations are crucial for new pharmaceutical products.
  • Statisticians require specialized methods for pharmaco-economic analyses.
  • Traditional clinical trial designs may not be optimal for economic assessments.

Purpose of the Study:

  • To investigate key statistical topics relevant to pharmaco-economic evaluations.
  • To address the appropriateness of randomized clinical trials for economic studies.
  • To examine methods for handling cost-effectiveness ratio data and inferential apparatus.

Main Methods:

  • Review of statistical methodologies for economic evaluations in pharmaceuticals.
  • Discussion on the design of clinical trials for economic endpoints.

Related Experiment Videos

  • Exploration of inferential techniques including hypothesis testing, confidence intervals, and Bayesian methods for cost-effectiveness data.

    • Main Results:

    • Traditional randomized clinical trials may require adaptation for economic evaluations.
    • Specific statistical approaches are needed for analyzing cost-effectiveness ratios.
    • The choice of inferential apparatus (hypothesis testing, confidence intervals, Bayesian methods) impacts results.

    Conclusions:

    • Statisticians must consider specialized methods for pharmaceutical economic evaluations.
    • Adapting trial designs and employing appropriate statistical inference are essential for robust economic assessments.
    • Further research into optimal methods for handling cost-effectiveness data is warranted.